These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30023665)

  • 21. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.
    Liu Y; Lan X; Wu T; Lang J; Jin X; Sun X; Wen Q; An R
    Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis.
    Qiao PL; Gargesha M; Liu Y; Laney VEA; Hall RC; Vaidya AM; Gilmore H; Gawelek K; Scott BB; Roy D; Wilson DL; Lu ZR
    Magn Reson Imaging; 2022 Feb; 86():37-45. PubMed ID: 34801672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Fibronectin Extra-Domain B (EDB)-Specific Aptide (APTEDB) Radiolabelling with Technetium-99m as a Potent Targeted Tumour-Imaging Agent.
    Mohammadgholi M; Sadeghzadeh N; Erfani M; Abediankenari S; Abedi SM; Emrarian I; Jafari N; Behzadi R
    Anticancer Agents Med Chem; 2018; 18(2):277-285. PubMed ID: 28925879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CAR-T Therapy Targets Extra Domain B of Fibronectin Positive Solid Tumor Cells.
    Tang J; Liu N; Zhu Y; Li Y; Zhao X
    Immunol Invest; 2023 Nov; 52(8):985-996. PubMed ID: 37815216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI of breast tumor initiating cells using the extra domain-B of fibronectin targeting nanoparticles.
    Sun Y; Kim HS; Park J; Li M; Tian L; Choi Y; Choi BI; Jon S; Moon WK
    Theranostics; 2014; 4(8):845-57. PubMed ID: 24955145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the Efficacy of the Combination of RNAi of lncRNA DANCR with Chemotherapy to Treat Triple Negative Breast Cancer Using Magnetic Resonance Molecular Imaging.
    Nicolescu C; Kim J; Sun D; Lu ZR
    Bioconjug Chem; 2024 Mar; 35(3):381-388. PubMed ID: 38446033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
    Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
    Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of EDB Fibronectin in Plasma, Patient-Derived Xenograft Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tumor Tissues Using Immunoaffinity LC-MS/MS.
    Li F; Hooper AT; Golas J; Chang CB; Neubert H; King L
    J Proteome Res; 2022 Oct; 21(10):2331-2340. PubMed ID: 36049057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
    Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and
    Okarvi SM; Aljammaz I
    Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging.
    Nicolescu C; Schilb A; Kim J; Sun D; Hall R; Gao S; Gilmore H; Schiemann WP; Lu ZR
    Chem Biomed Imaging; 2023 Aug; 1(5):461-470. PubMed ID: 37655165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL.
    Li F; Zhang Z; Cheng T; Wei R; Dai Y; Lv M; Luo D; Zhu X; Ma D; Xi L; Dong Q; Ma X
    Amino Acids; 2016 Jan; 48(1):91-101. PubMed ID: 26255282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of fibronectin isoforms in human breast tissue: production of extra domain A+/extra domain B+ by cancer cells and extra domain A+ by stromal cells.
    Matsumoto E; Yoshida T; Kawarada Y; Sakakura T
    Jpn J Cancer Res; 1999 Mar; 90(3):320-5. PubMed ID: 10359047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells.
    Ventura E; Weller M; Macnair W; Eschbach K; Beisel C; Cordazzo C; Claassen M; Zardi L; Burghardt I
    J Cell Sci; 2018 Jan; 131(1):. PubMed ID: 29158223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CAR-T-Cell Therapy for Solid Tumors Positive for Fibronectin Extra Domain B.
    Zhang Z; Liu C; Yang Z; Yin H
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice.
    Coltrini D; Ronca R; Belleri M; Zardi L; Indraccolo S; Scarlato V; Giavazzi R; Presta M
    J Pathol; 2009 Dec; 219(4):455-62. PubMed ID: 19824060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
    Fu P; Shen B; Zhao C; Tian G
    J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer.
    Han Z; Xiao Y; Wang K; Yan J; Xiao Z; Fang F; Jin Z; Liu Y; Sun X; Shen B
    J Nucl Med; 2018 Nov; 59(11):1686-1691. PubMed ID: 29777004
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.